ESR1 and hepatocellular carcinoma: Previous epidemiological cohort studies identified an association of higher androgen/androgen receptor (AR) pathway activity with a higher risk of HCC in male HBV carriers [90,91]; by contrast, an inverse correlation between estrogen receptor pathway and HCC risk was found in female HBV carriers [92].